A detailed history of Hollencrest Capital Management transactions in Becton Dickinson & CO stock. As of the latest transaction made, Hollencrest Capital Management holds 81 shares of BDX stock, worth $18,536. This represents 0.0% of its overall portfolio holdings.

Number of Shares
81
Previous 96 15.63%
Holding current value
$18,536
Previous $23,000 13.04%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

SELL
$233.45 - $247.73 $3,501 - $3,715
-15 Reduced 15.63%
81 $20,000
Q4 2023

Feb 14, 2024

BUY
$232.24 - $267.23 $20,901 - $24,050
90 Added 1500.0%
96 $23,000
Q1 2023

May 16, 2023

SELL
$229.71 - $259.35 $1,148 - $1,296
-5 Reduced 45.45%
6 $1,000
Q4 2022

Feb 06, 2023

BUY
$218.29 - $256.91 $2,401 - $2,826
11 New
11 $2,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.3B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Hollencrest Capital Management Portfolio

Follow Hollencrest Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hollencrest Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Hollencrest Capital Management with notifications on news.